In this paper, we validated our previous findings for the 4 most promising candidate biomarker proteins (GFAP, NEFL, MMP3 and FABP4) and extended our previous observations by using a larger and more diverse set of well-characterized samples from benign and malignant primary and secondary brain tumors. The gene discussed is FABP4; the disease is brain neoplasm.